(S (NP (NP (NN Drug) (NN promiscuity)) (CC and) (NP (NN polypharmacology))) (VP (VBP are) (ADVP (JJ much)) (VP (VBN discussed) (NP (NNS topics)) (PP (IN in) (NP (JJ pharmaceutical) (NN research))))) (. .))
(S (NP (NP (NN Drug)) (VP (VBG repositioning))) (VP (VBZ applies) (NP (VBN established) (NNS drugs)) (PP (IN to) (NP (JJ new) (NN disease) (NNS indications))) (PP (IN with) (NP (VBG increasing) (NN success)))) (. .))
(S (S (PP (IN As) (NP (NN polypharmacology))) (, ,) (VP (VBD defined) (NP (NP (DT a) (NN drug) (POS 's)) (NN ability) (S (VP (TO to) (VP (VB bind) (PP (PP (IN to) (NP (JJ several) (NNS targets))) (CC but) (PP (IN due) (PP (IN to) (NP (JJ possible) (NN side) (NNS effects))))))))))) (, ,) (NP (DT this) (NN feature)) (VP (VBZ is) (RB not) (VP (VBN taken) (PP (IN into) (NP (NN consideration))))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP (DT the) (JJ pharmaceutical) (NN industry)) (VP (VBD focused) (PP (IN on) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (ADJP (RB highly) (JJ selective)) (NML (JJ single) (HYPH -) (NN target)) (NNS drugs)))))) (. .))
(S (PP (ADVP (RB Nowadays)) (IN after) (NP (NP (NN lot)) (PP (IN of) (NP (NNS researches))))) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ clear)) (SBAR (IN that) (S (NP (NN polypharmacology)) (VP (VBZ is) (ADJP (JJ important) (PP (IN for) (NP (NP (DT the) (NN efficacy)) (PP (IN of) (NP (NNS drugs)))))))))) (. .))
(S (S (NP (EX There)) (VP (VBP are) (NP (JJ side) (NNS effects)))) (CC but) (S (PP (IN on) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (DT this)) (VP (VBZ gives) (NP (DT the) (NN opportunity) (S (VP (TO to) (VP (VB uncover) (NP (NP (JJ new) (NNS uses)) (PP (PP (IN for) (NP (ADJP (RB already) (VBN known)) (NNS drugs))) (CC and) (RB especially) (PP (IN for) (NP (JJ complex) (NNS diseases))))))))))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP (PRP it)) (VP (VBZ is) (ADJP (JJ clear)) (SBAR (IN that) (S (NP (EX there)) (VP (VBP are) (NP (NP (CD two) (NNS sides)) (PP (IN of) (NP (DT the) (JJ same) (NN coin)))))))) (. .))
(S (NP (EX There)) (VP (VBP are) (NP (JJ several) (NNS approaches) (S (VP (TO to) (VP (VB discover) (NP (JJ new) (NNS drugs) (NNS targets)) (, ,) (PP (IN as) (NP (NP (NP (NN analysis)) (PP (IN of) (NP (ADJP (NN genome) (JJ wide)) (NN association)))) (, ,) (NP (NML (NN gene) (NN expression)) (NNS data) (CC and) (NNS networks)) (, ,) (NP (NP (JJ structural) (NNS approaches)) (PP (IN with) (NP (NP (NN alignment) (NNS methods)) (ADVP (FW etc.)))))))))))) (. .))
(S (NP (NP (JJ Computational) (NN drug) (NN discovery)) (CC and) (NP (NN design))) (VP (VBZ has) (VP (VBN experienced) (NP (DT a) (JJ rapid) (NN increase)) (PP (IN in) (NP (NP (NN development)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (PP (ADVP (RB mainly)) (IN due) (IN to) (NP (NP (DT the) (VBG increasing) (NN cost)) (PP (IN for) (S (VP (VBG discovering) (NP (JJ new) (NNS compounds)))))))))))))) (. .))
(S (SBAR (IN Since) (S (NP (NN drug) (NN development)) (VP (VBZ is) (NP (DT a) (ADJP (RB very) (JJ costly)) (NN venture))))) (, ,) (NP (DT the) (JJ pharmaceutical) (NN industry)) (VP (VBZ puts) (NP (NN effort)) (PP (IN in) (NP (NP (DT the) (VBG repositioning)) (PP (IN of) (NP (ADJP (ADJP (VBN withdrawn)) (CC or) (ADJP (RB already) (VBN approved))) (NNS drugs)))))) (. .))
(S (NP (NP (DT The) (NNS costs)) (PP (IN for) (S (VP (VBG bringing) (NP (PDT such) (DT a) (NN drug)) (PP (IN to) (NP (NN market))))))) (VP (VBP are) (ADJP (ADJP (NP (CD 60) (NN %)) (JJR lower)) (PP (IN than) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (DT a) (JJ novel) (NN drug)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ costs) (NP (QP (RB roughly) (CD one) (CD billion)) (NNP US) (NNS dollars))))))))))) (. .))
(S (ADVP (RB Thus)) (, ,) (NP (NP (NN target) (NN prediction)) (, ,) (NP (ADJP (NN drug) (VBG repositioning)) (NNS approaches)) (, ,) (NP (NML (NN protein) (HYPH -) (NN ligand)) (NN docking)) (CC and) (NP (NP (VBG scoring) (NNS algorithms)) (, ,) (NP (JJ virtual) (NN screening)) (CC and) (NP (JJ other) (JJ computational) (NNS techniques)))) (VP (VBP have) (VP (VBN gained) (NP (NP (DT the) (NN interest)) (PP (IN of) (NP (NP (NNS researchers)) (CC and) (NP (JJ pharmaceutical) (NNS companies))))))) (. .))
